Transplanted stem cells help build a 'biobridge' which links uninjured brain regions to those damaged as a result of TBI, a new study shows.
A new method for obtaining mature neuronal cells from reprogrammed skin cells allows researchers to safely and effectively study diseases such as schizophrenia and autism.
Researchers identify a protein that appears to be the target of both antidepressant drugs and electroconvulsive therapy. The experimental results explain how these therapies likely work to relieve depression by stimulating stem cells in the brain to grow and mature.
Researchers were able to regenerate an astonishing degree of axonal growth at the site of severe spinal cord injury in rats. Results were then replicated using two human stem cell lines, one already in human trials for ALS. “We obtained the exact results using human cells as we had in the rat cells,” said Tuszynski.
Stem Cell Research Paves way for Progress on Dealing with Fragile X Retardation Researchers at the Hebrew University of Jerusalem...
NT-020, a combination of nutrients, increased neural stem cell proliferation, neurogenesis and helped improve memory in the aging brains of mice.